Literature DB >> 7299915

Regional lymph node metastasis from bladder cancer.

J A Smith, W F Whitmore.   

Abstract

The prognosis for patients with bladder cancer metastatic to regional lymph nodes is dismal and only minimally altered by current treatment modalities. The 5-year survival rate after radical cystectomy for 134 bladder cancer patients with positive regional lymph nodes was only 7 per cent and 82 per cent of the patients died of bladder cancer. Stratification of patients into groups with varying extent of nodal disease showed a correlation between the level of nodal involvement and the interval to recurrence. While 38 per cent of the patients died of distant disease alone 25 per cent had only pelvic recurrence, indicating a possible therapeutic effect of a systmatic bilateral pelvic lymphadenectomy and implicating extrapelvic disease as a major determinant of patient survival.

Entities:  

Mesh:

Year:  1981        PMID: 7299915     DOI: 10.1016/s0022-5347(17)54638-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Evaluation of imaging methods in the diagnosis of vesical tumours.

Authors:  J Rózsahegyi; P Magasi
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

3.  Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).

Authors:  P H Smith; J A Child; J H Mulder; A T Van Oosterom; J A Martinez-Pineiro; B Richards; G Stoter; O Dalesio; M De Pauw; R Sylvester
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  Chemotherapy in the management of bladder tumours.

Authors:  W F Whitmore; A Yagoda
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

5.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 6.  Adjuvant chemotherapy following radical cystectomy.

Authors:  C N Sternberg
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

Review 8.  [Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].

Authors:  F vom Dorp; C Börgermann; M Schenck; M Becker; A Rose; T Szarvas; H Rübben
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

9.  Transurethral resection of 1250 bladder tumours.

Authors:  J Kondás; E Szentgyörgyi
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

10.  Chemoimmune prophylaxis of superficial bladder tumors: results after treatment of 130 patients in 4 years.

Authors:  H D Adolphs; H P Bastian
Journal:  Urol Res       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.